Oncology - European Medical Journal

Continue

Oncology

Filter
11 May 2017

University Research Opens Door to U.S. Market for UK Chemotherapy Scalp Cooling Firm

Huddersfield, UK, 10 May, 2017 – A pioneering UK company that produces technology designed to reduce hair loss during cancer treatment has been given…
9 May 2017

Introducing EMJ Urology 5.1

United Kingdom, May 09, 2017: Welcome to the newest edition of our EMJ Urology eJournal, packed with the latest urological developments. This issue is…
2 May 2017

New Hope in Fight Against Pancreatic Cancer

MIR506, a small microRNA molecule, could be the key to new treatments to suppress deadly and aggressive pancreatic cancer, a new study has found. Through…
26 Apr 2017

European Society for Medical Oncology (ESMO): Annual Flu Jab May Pose Greater Risk for Lung Cancer Patients Under Immunotherapy

Geneva, Switzerland, 26 April, 2017 – Lung cancer patients treated with immunotherapy may be at increased risk of adverse events after receiving the…
5 Apr 2017

RedHill Biopharma Receives FDA Orphan Drug Designation for YELIVA® for the Treatment of Cholangiocarcinoma

Tel-Aviv, Israel, April 04, 2017 – RedHill Biopharma Ltd. (NASDAQ: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), a specialty…
5 Apr 2017

Australia’s Bionic Vision Technologies Raises US$18 Million (AU$23.5 M) to Develop ‘Bionic Eye’ for Global Markets

Melbourne, Australia, April 03, 2017 – Retinal implant innovator Bionic Vision Technologies (BVT) today announced it had raised US $18 million…
28 Mar 2017

Selvita and Menarini Group Announce Global License Agreement for Clinical Stage Oncology Drug PIM/FLT3 Inhibitor SEL24

Krakow, Poland / Berlin, Germany, March 28, 2017 – Selvita S.A. (WSE:SLV), and Berlin-Chemie Menarini, a company of the Menarini Group, announced today…
27 Mar 2017

Promising Results from Phase II Trial of Renal Cancer Drug

RESULTS published from a Phase II clinical trial have shown the potential of the investigational drug savolitinib in the treatment of c-MET-driven…